tripelennamine has been researched along with haloperidol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Eckstein, JW; Mark, AL; Schmid, PG; Schuelke, DM | 1 |
| Katz, RJ; Sibel, M | 1 |
4 other study(ies) available for tripelennamine and haloperidol
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Coronary vasodilatation produced by dopamine after adrenergic blockade.
Topics: Animals; Blood Pressure; Coronary Vessels; Dilatation; Dogs; Dopamine; Dopamine Antagonists; Drug Antagonism; Haloperidol; Hexamethonium Compounds; Isoproterenol; Nitroglycerin; Perfusion; Phentolamine; Propranolol; Receptors, Adrenergic; Regional Blood Flow; Tripelennamine; Vagotomy; Vasodilator Agents; Ventricular Function | 1971 |
Further analysis of the specificity of a novel animal model of depression--effects of an antihistaminic, antipsychotic and anxiolytic compound.
Topics: Animals; Corticosterone; Depressive Disorder; Disease Models, Animal; Exploratory Behavior; Haloperidol; Humans; Male; Motivation; Motor Activity; Oxazepam; Rats; Rats, Inbred Strains; Stress, Physiological; Tripelennamine | 1982 |